Accumulation of lipid peroxide in the content of comedones may be involved in the progression of comedogenesis and inflammatory changes in comedones

Journal of Cosmetic Dermatology

Volumn 8, Issue 2, 2009, Pages 152-158

  Tochio, Takumi ^a   Tanaka, Hiroshi ^a   Nakata, Satoru ^a   Ikeno, Hiroshi ^b  

^a Nippon Menard Cosmetic Co Ltd   (Japan)

^b Ikeno Clinic of Dermatology and Dermatologic Surgery   (Japan)

Author keywords

Acne vulgaris; Comedones; Lipid peroxide

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; LIPID PEROXIDE;

ACNE VULGARIS; ADULT; ARTICLE; CLINICAL ARTICLE; COMEDO; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; INFLAMMATION; INFLAMMATORY CLOSED COMEDO; INFLAMMATORY OPEN COMEDO; LIPID STORAGE; MALE; MICROCOMEDO; NONINFLAMMATORY CLOSED COMEDO; NONINFLAMMATORY OPEN COMEDO; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN DISEASE; STRATUM CORNEUM;

ACNE VULGARIS; BIOLOGICAL MARKERS; CERAMIDES; CHOLESTEROL; FATTY ACIDS, NONESTERIFIED; HUMANS; INTERLEUKIN-1ALPHA; LIPID PEROXIDATION; LIPID PEROXIDES; LIPIDS; NF-KAPPA B; SEBUM;

EID: 66949129751     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2009.00437.x     Document Type: Article

References (19)

1. Strauss JS, Pochi PE, Downing DT. Acne: Perspectives. J Invest Dermatol 1974; 62: 321-5.
2. Downing DT, Stewart ME, Wertz PW, Strauss JS. Essential fatty acids and acne. J Am Acad Dermatol 1986; 14: 221-5.
3. Yamamoto A, Takenouchi K, Ito M. Impaired water barrier function in acne vulgaris. Arch Dermatol Res 1995; 287: 214-8.
4. Melnik B, Kinner T, Plewig G. Influence of oral isotretinoin treatment on the composition of comedonal lipids. Implications for comedogenesis in acne vulgaris. Arch Dermatol Res 1988; 280: 97-102.
5. Guy R, Green MR, Kealey T. Modeling acne in vitro. J Invest Dermatol 1996; 106: 176-82.
6. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002; 169: 1535-41.
7. Heymann WR. Toll-like receptors in acne vulgaris. J Am Acad Dermatol 2006; 55: 691-2.
8. Ayres S Jr, Mihan R. Acne vulgaris and lipid peroxidation: New concepts in pathogenesis and treatment. Int J Dermatol 1978; 17: 305-7.
9. Motoyoshi K. Enhanced comedo formation in rabbit ear skin by squalene and oleic acid peroxides. Br J Dermatol 1983; 109: 191-8.
10. Chiba K, Yoshizawa K, Makino I, Kawakami K, Onoue M. Comedogenicity of squalene monohydroperoxide in the skin after topical application. J Toxicol Sci 2000; 25: 77-83.
11. Ottaviani M, Alestas T, Flori E, Mastrofrancesco A, Zouboulis CC, Picardo M. Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: A possible role in acne vulgaris. J Invest Dermatol 2006; 126: 2430-7.
12. Ikeno H, Ohmori K, Yunoki S, Nishikawa T. Open study comparing 5% sodium l-ascorbyl-2-phosphate lotion versus 1% clindamycin phosphate lotion for acne vulgaris. Cosmet Dermatol 2006; 19: 43-48.
13. Ikeno H, Ohmori K. Open study comparing sodium l-ascorbyl-2-phosphate 5% lotion versus adapalene 0.1% gel for acne vulgaris. Cosmet Dermatol 2007; 20: 368-72.
14. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86: 271-8.
15. Kligman AM, Plewig G. Acne and Rosacea, 2nd completely revised and enlarged edition, Berlin: Spring-Verlag; 1993: 75.
16. Meguro H, Akasaka K, Ohrui H. Determination of hydroperoxides with fluorometric reagent diphenyl-1-pyrenylphosphine. Methods Enzymol 1990; 186: 157-61.
17. Wollina U, Knöll B, Prüfer K, Barth A, Müller D, Huschenbeck J. Synthetic wound dressings - evaluation of interactions with epithelial and dermal cells in vitro. Skin Pharmacol 1996; 9: 35-42.
18. Pöppelmann B, Klimmek K, Strozyk E, Voss R, Schwarz T, Kulms D. NF{kappa}B-dependent down-regulation of tumor necrosis factor receptor-associated proteins contributes to interleukin-1-mediated enhancement of ultraviolet B-induced apoptosis. J Biol Chem 2005; 280: 15635-43.
19. Wolf JS, Chen Z, Dong G, Sunwoo JB, Bancroft CC, Capo DE, Yeh NT, Mukaida N, Van Waes C. IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 2001; 7: 1812-20.